A$0.29 0.0 0.0%
Last Trade - 25/02/21
| Market Cap | £22.2m |
| Enterprise Value | £10.3m |
| Revenue | £22.0m |
| Position in Universe | 1162nd / 1831 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 30th Jun | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 6.70 | 9.40 | 9.84 | 10.9 | 21.6 | 39.1 | +42.3% | ||||
| -41.9 | +670 | -10.1 | ||||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Star Combo Pharma Limited is an Australia-based company that provides nutritional products. The Company develops, manufactures and distributes a range of vitamins, dietary supplements and skincare products. It sells the products under various brands, including Costar, Amax, J&K and Living Healthy. Its products include Costar Royal Jelly, Costar Lanolin and VE Cream, Costar Propolis and Costar Colostrum. It manufactures and distributes its health products within Australia and across Asia. It also manufactures therapeutic goods for other pharmaceutical or nutritional brand owners. It sells its products in Australia through retail channels, such as souvenir, convenience and grocery stores, and Terry White pharmacy stores. It also sells products through its Website, as well as various online e-commerce platforms, such as Taobao and JD. Its subsidiaries include Star Combo Australia Pty Ltd and Costar Pharma Laboratory Pty Ltd.
| Last Annual | June 30th, 2020 |
| Last Interim | June 30th, 2020 |
| Incorporated | November 4, 2016 |
| Public Since | May 16, 2018 |
| No. of Shareholders: | 664 |
| No. of Employees: | n/a |
| Sector | Consumer Cyclicals |
| Industry | Specialty Retailers |
| Index | |
| Exchange | Australian Stock Exchange - SEATS |
| Shares in Issue | 135,616,601 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Smithfield 171 - 177 Woodpark Road, Sydney, 2164, Australia |
| Web | http://www.starcombo.com.au/ |
| Phone | +61 2 97566555 |
| Contact | () |
| Auditors | BDO East Coast Partnership |
As of 25/02/21, shares in Star Combo Pharma are trading at A$0.29, giving the company a market capitalisation of £22.2m. This share price information is delayed by 15 minutes.
Shares in Star Combo Pharma are currently trading at A$0.29 and the price has moved by -42% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Star Combo Pharma price has moved by -44.57% over the past year.
There are no analysts currently covering Star Combo Pharma.
Star Combo Pharma is scheduled to issue upcoming financial results on the following dates:
Star Combo Pharma does not currently pay a dividend.
Star Combo Pharma does not currently pay a dividend.
Star Combo Pharma does not currently pay a dividend.
To buy shares in Star Combo Pharma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Star Combo Pharma are currently trading at A$0.29, giving the company a market capitalisation of £22.2m.
Here are the trading details for Star Combo Pharma:
Based on an overall assessment of its quality, value and momentum, Star Combo Pharma is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We were not able to load any forecast data for Star Combo Pharma.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Star Combo Pharma. Over the past six months, the relative strength of its shares against the market has been -29.19%. At the current price of A$0.29, shares in Star Combo Pharma are trading at -30.89% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Star Combo Pharma.
We were unable to find the directors for Star Combo Pharma.
Here are the top five shareholders of Star Combo Pharma based on the size of their shareholding:
